final action
on 13 May 2024
Last Applicant/ Owned by
20 Burton Hills Blvd, Ste 150
Nashville
TN
37215
Serial Number
98170615 filed on 08th Sep 2023
Registration Number
N/A
Correspondent Address
BENJAMIN W. JANKE BAKER, DONELSON, BEARMAN, CALDWELL & BERKOWITZ, PC
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting research and clinical Read More
Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients
28th Feb 2023
28th Feb 2023
Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, including analysis of value-based care, care coordination, decision-making services, and insights, as well as the evaluation of oncology clinical research studies for patient access and participation in clinical trials; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer
28th Feb 2023
28th Feb 2023
Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, contract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes
28th Feb 2023
28th Feb 2023
No 98170615
No Service Mark
No 2957756.3
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 13th May 2024 | NON-FINAL ACTION E-MAILED |
| 13th May 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 13th May 2024 | NON-FINAL ACTION WRITTEN |
| 03rd May 2024 | ASSIGNED TO EXAMINER |
| 29th Sep 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 12th Sep 2023 | NEW APPLICATION ENTERED |
